Legis Daily

To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes.

USA115th CongressHR-5806| House 
| Updated: 5/17/2018
Michael C. Burgess

Michael C. Burgess

Republican Representative

Texas

Cosponsors (4)
Marsha Blackburn (Republican)Greg Walden (Republican)H. Morgan Griffith (Republican)Larry Bucshon (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
21st Century Tools for Pain and Addiction Treatment Act This bill requires the Food and Drug Administration (FDA) to revise how it will address the challenges and barriers of developing non-addictive medical products to treat pain or addiction.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Ordered to be Reported by the Yeas and Nays: 31 - 23.
May 17, 2018
Committee Consideration and Mark-up Session Held.
  • May 15, 2018
    Introduced in House
  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.
  • May 17, 2018
    Ordered to be Reported by the Yeas and Nays: 31 - 23.
  • May 17, 2018
    Committee Consideration and Mark-up Session Held.

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • S 115-2680: Opioid Crisis Response Act of 2018
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesFood and Drug Administration (FDA)Public participation and lobbying

To require the Secretary of Health and Human Services to issue guidance with respect to the expedited approval of certain drugs, and for other purposes.

USA115th CongressHR-5806| House 
| Updated: 5/17/2018
21st Century Tools for Pain and Addiction Treatment Act This bill requires the Food and Drug Administration (FDA) to revise how it will address the challenges and barriers of developing non-addictive medical products to treat pain or addiction.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
May 15, 2018
Introduced in House
May 15, 2018
Referred to the House Committee on Energy and Commerce.
May 17, 2018
Ordered to be Reported by the Yeas and Nays: 31 - 23.
May 17, 2018
Committee Consideration and Mark-up Session Held.
  • May 15, 2018
    Introduced in House
  • May 15, 2018
    Referred to the House Committee on Energy and Commerce.
  • May 17, 2018
    Ordered to be Reported by the Yeas and Nays: 31 - 23.
  • May 17, 2018
    Committee Consideration and Mark-up Session Held.
Michael C. Burgess

Michael C. Burgess

Republican Representative

Texas

Cosponsors (4)
Marsha Blackburn (Republican)Greg Walden (Republican)H. Morgan Griffith (Republican)Larry Bucshon (Republican)

Energy and Commerce Committee

Health

Related Bills

  • HR 115-6: SUPPORT for Patients and Communities Act
  • S 115-2680: Opioid Crisis Response Act of 2018
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesFood and Drug Administration (FDA)Public participation and lobbying